322 related articles for article (PubMed ID: 18046009)
1. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
Pennell PB; Peng L; Newport DJ; Ritchie JC; Koganti A; Holley DK; Newman M; Stowe ZN
Neurology; 2008 May; 70(22 Pt 2):2130-6. PubMed ID: 18046009
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy.
Ding Y; Tan X; Zhang S; Guo Y
Brain Behav; 2019 Jul; 9(7):e01315. PubMed ID: 31104352
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine clearance during pregnancy.
Tran TA; Leppik IE; Blesi K; Sathanandan ST; Remmel R
Neurology; 2002 Jul; 59(2):251-5. PubMed ID: 12136066
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy.
Voinescu PE; Park S; Chen LQ; Stowe ZN; Newport DJ; Ritchie JC; Pennell PB
Neurology; 2018 Sep; 91(13):e1228-e1236. PubMed ID: 30185446
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
Ohman I; Beck O; Vitols S; Tomson T
Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
[TBL] [Abstract][Full Text] [Related]
6. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period.
Fotopoulou C; Kretz R; Bauer S; Schefold JC; Schmitz B; Dudenhausen JW; Henrich W
Epilepsy Res; 2009 Jul; 85(1):60-4. PubMed ID: 19272754
[TBL] [Abstract][Full Text] [Related]
7. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.
de Haan GJ; Edelbroek P; Segers J; Engelsman M; Lindhout D; Dévilé-Notschaele M; Augustijn P
Neurology; 2004 Aug; 63(3):571-3. PubMed ID: 15304599
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.
Ohman I; Vitols S; Tomson T
Epilepsia; 2000 Jun; 41(6):709-13. PubMed ID: 10840403
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.
Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ
Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354
[TBL] [Abstract][Full Text] [Related]
10. The impact of pregnancy and childbirth on the metabolism of lamotrigine.
Pennell PB; Newport DJ; Stowe ZN; Helmers SL; Montgomery JQ; Henry TR
Neurology; 2004 Jan; 62(2):292-5. PubMed ID: 14745072
[TBL] [Abstract][Full Text] [Related]
11. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
12. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic changes for newer antiepileptic drugs and seizure control during pregnancy.
Yin X; Liu Y; Guo Y; Zhao L; Li G; Tan X
CNS Neurosci Ther; 2022 May; 28(5):658-666. PubMed ID: 35037389
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine clearance increases by 5 weeks gestational age: Relationship to estradiol concentrations and gestational age.
Karanam A; Pennell PB; French JA; Harden CL; Allien S; Lau C; Barnard S; Callisto SP; Birnbaum AK
Ann Neurol; 2018 Oct; 84(4):556-563. PubMed ID: 30168175
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring in pregnancy: Levetiracetam.
Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
[TBL] [Abstract][Full Text] [Related]
16. Seizure frequency in pregnant women treated with lamotrigine monotherapy.
Sabers A; Petrenaite V
Epilepsia; 2009 Sep; 50(9):2163-6. PubMed ID: 19490048
[TBL] [Abstract][Full Text] [Related]
17. Individual changes in lamotrigine plasma concentrations during pregnancy.
Petrenaite V; Sabers A; Hansen-Schwartz J
Epilepsy Res; 2005 Jul; 65(3):185-8. PubMed ID: 16084694
[TBL] [Abstract][Full Text] [Related]
18. UGT polymorphisms and lamotrigine clearance during pregnancy.
Petrenaite V; Öhman I; Ekström L; Sæbye D; Hansen TF; Tomson T; Sabers A
Epilepsy Res; 2018 Feb; 140():199-208. PubMed ID: 29395496
[TBL] [Abstract][Full Text] [Related]
19. Dose Monitoring of Lamotrigine Monotherapy in Pregnancy: Are Pregnant Women with Epilepsy Currently Optimally Managed? A Systematic Review.
Goo Y; der Nederlanden AM; Bleasel A; Alffenaar JW; Kim HY
Ther Drug Monit; 2024 Apr; 46(2):181-194. PubMed ID: 38366344
[TBL] [Abstract][Full Text] [Related]
20. Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis.
Pirie DA; Al Wattar BH; Pirie AM; Houston V; Siddiqua A; Doug M; Bagary M; Greenhill L; Khan KS; McCorry D; Thangaratinam S
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():26-31. PubMed ID: 24211103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
